Showing codes 69097-866-85 Rizatriptan Benzoate — 69097-893-93 Sevelamer Carbonate

69097-866-85 - Rizatriptan Benzoate
Firm: Cipla USA Inc.
Package Description: 3 TABLET in 1 CARTON (69097-866-85)
Usage type: ORAL
HTML TXT

69097-867-02 - Nadolol
Firm: Cipla USA Inc.
Package Description: 30 TABLET in 1 BOTTLE (69097-867-02)
Usage type: ORAL
HTML TXT

69097-867-07 - Nadolol
Firm: Cipla USA Inc.
Package Description: 100 TABLET in 1 BOTTLE (69097-867-07)
Usage type: ORAL
HTML TXT

69097-867-15 - Nadolol
Firm: Cipla USA Inc.
Package Description: 1000 TABLET in 1 BOTTLE (69097-867-15)
Usage type: ORAL
HTML TXT

69097-868-02 - Nadolol
Firm: Cipla USA Inc.
Package Description: 30 TABLET in 1 BOTTLE (69097-868-02)
Usage type: ORAL
HTML TXT

69097-868-07 - Nadolol
Firm: Cipla USA Inc.
Package Description: 100 TABLET in 1 BOTTLE (69097-868-07)
Usage type: ORAL
HTML TXT

69097-868-15 - Nadolol
Firm: Cipla USA Inc.
Package Description: 1000 TABLET in 1 BOTTLE (69097-868-15)
Usage type: ORAL
HTML TXT

69097-869-02 - Nadolol
Firm: Cipla USA Inc.
Package Description: 30 TABLET in 1 BOTTLE (69097-869-02)
Usage type: ORAL
HTML TXT

69097-869-07 - Nadolol
Firm: Cipla USA Inc.
Package Description: 100 TABLET in 1 BOTTLE (69097-869-07)
Usage type: ORAL
HTML TXT

69097-869-15 - Nadolol
Firm: Cipla USA Inc.
Package Description: 1000 TABLET in 1 BOTTLE (69097-869-15)
Usage type: ORAL
HTML TXT

69097-870-67 - Lanreotide Acetate
Firm: Cipla USA Inc.
Package Description: 1 SYRINGE in 1 CARTON (69097-870-67) / .5 mL in 1 SYRINGE
Usage type: SUBCUTANEOUS
HTML TXT

69097-875-02 - Bupropion Hydrochloride
Firm: CIPLA USA INC.,
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-02)
Usage type: ORAL
HTML TXT

69097-875-05 - Bupropion Hydrochloride
Firm: CIPLA USA INC.,
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-05)
Usage type: ORAL
HTML TXT

69097-875-12 - Bupropion Hydrochloride
Firm: CIPLA USA INC.,
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-875-12)
Usage type: ORAL
HTML TXT

69097-876-02 - Bupropion Hydrochloride
Firm: CIPLA USA INC.,
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-876-02)
Usage type: ORAL
HTML TXT

69097-876-12 - Bupropion Hydrochloride
Firm: CIPLA USA INC.,
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-876-12)
Usage type: ORAL
HTML TXT

69097-877-02 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-02)
Usage type: ORAL
HTML TXT

69097-877-03 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-03)
Usage type: ORAL
HTML TXT

69097-877-07 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-07)
Usage type: ORAL
HTML TXT

69097-877-12 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-877-12)
Usage type: ORAL
HTML TXT

69097-878-02 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-02)
Usage type: ORAL
HTML TXT

69097-878-03 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-03)
Usage type: ORAL
HTML TXT

69097-878-07 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-07)
Usage type: ORAL
HTML TXT

69097-878-12 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-12)
Usage type: ORAL
HTML TXT

69097-879-02 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-879-02)
Usage type: ORAL
HTML TXT

69097-879-03 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-879-03)
Usage type: ORAL
HTML TXT

69097-879-07 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-879-07)
Usage type: ORAL
HTML TXT

69097-879-12 - Bupropion Hydrochloride (sr)
Firm: Cipla USA Inc.,
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-879-12)
Usage type: ORAL
HTML TXT

69097-880-67 - Lanreotide Acetate
Firm: Cipla USA Inc.
Package Description: 1 SYRINGE in 1 CARTON (69097-880-67) / .2 mL in 1 SYRINGE
Usage type: SUBCUTANEOUS
HTML TXT

69097-890-67 - Lanreotide Acetate
Firm: Cipla USA Inc.
Package Description: 1 SYRINGE in 1 CARTON (69097-890-67) / .3 mL in 1 SYRINGE
Usage type: SUBCUTANEOUS
HTML TXT

69097-893-93 - Sevelamer Carbonate
Firm: Cipla USA Inc.
Package Description: 270 TABLET, FILM COATED in 1 BOTTLE (69097-893-93)
Usage type: ORAL
HTML TXT

Current Page # is: 14054
Ones	0	1	2	3	4	5	6	7	8	9
Tens	0	1	2	3	4	5	6	7	8	9
Hundreds	0	1	2	3	4	5	6	7	8	9
Thousands	0	1	2	3	4	5	6	7	8	9
Tens of Thousands	0	1